Tag
This review synthesizes current evidence on low-carbohydrate diets in gestational diabetes mellitus (GDM), highlighting effects on glycemia, nutrient adequacy, and perinatal outcomes from the DiGest trial and supporting literature.
GLP-1 receptor agonists are increasingly used in women of reproductive age, but their safety during periconception and pregnancy remains unclear. Current observational data show no definitive harm, yet robust evidence is lacking, emphasizin
This study assesses whether estimated fetal weight growth velocity improves prediction of adverse perinatal outcomes in term pregnancies with estimated fetal weight below the 10th centile, finding no additional benefit beyond Doppler and bi
This study examines how bariatric surgery and gestational diabetes mellitus independently and jointly impact maternal and neonatal outcomes, highlighting increased risks and the need for personalized antenatal care.
In a large retrospective cohort, most stillbirths and composite adverse outcomes occurred among pregnancies with a normal ultrasound at 35–36 weeks, despite high detection of severe small-for-gestational-age infants.
In a retrospective cohort of pregnancies complicated by type 2 diabetes, gestational weight gain under 5 kg was associated with lower odds of several adverse perinatal outcomes without a statistically significant rise in preterm birth or sm
This review synthesizes recent evidence suggesting that weight gain <5 kg in pregnant individuals with type 2 diabetes significantly reduces risks of LGA, hypertensive disorders, and NICU admissions without increasing SGA rates.
Study reveals inadequate hemoglobin improvement at 20-24 weeks after iron therapy increases stillbirth and preterm birth risks in moderate iron deficiency anemia pregnancies, highlighting need for early intervention.
A randomized trial of 205 pregnant women with gestational diabetes found that adjunctive flash glucose monitoring did not improve time-in-range glucose measurements compared to standard self-monitoring. However, the device was associated wi
This population-based cohort study of over 1 million births reveals that maternal multiple chronic conditions (MCC) significantly increase the risk of severe neonatal morbidity and mortality, with risks escalating alongside the number, comp
Vaccination against SARS-CoV-2 during pregnancy significantly lowers risks of severe maternal COVID-19, hospitalization, critical care admission, and preterm birth across variant periods, underscoring its safety and efficacy for maternal an
The DipGluMo trial found that real-time continuous glucose monitoring does not improve perinatal outcomes versus self-monitoring in gestational diabetes, but is preferred by patients for ease of use.
